<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="migraine/PMC6826633/results/search/disease/results.xml">
  <result pre="Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/). Abstract Neurostimulation for" exact="epilepsy" post="refers to the application of electricity to affect the"/>
  <result pre="order to establish optimal stimulation paradigms. pediatric neurostimulation neuromodulation drug-resistant" exact="epilepsy" post="vagus nerve stimulation responsive neurostimulation deep brain stimulation chronic"/>
  <result pre="unlikely to be seizure-free by using medications alone, and the" exact="epilepsy" post="is termed pharma-co-resistant [ 1, 2, 3]. Other treatment"/>
  <result pre="for neurostimulation, and the evidence to support their use for" exact="epilepsy" post="in pediatric patients. We consider possible mechanisms of action,"/>
  <result pre="only a single randomized controlled trial for neurostimulation in pediatric" exact="epilepsy" post="[ 13]. The remainder of the evidence is limited"/>
  <result pre="nerve stimulation (VNS) gained US FDA approval for intractable focal" exact="epilepsy" post="in 1997, and is now approved for patients aged"/>
  <result pre="VNS devices have been implanted worldwide for the treatment of" exact="epilepsy" post="[ 16]. 2.2. Mechanism VNS is theorized to modulate"/>
  <result pre="in heart rate, based upon the observation that 82% of" exact="epilepsy" post="patients experience ictal tachycardia [ 30]. One study suggested"/>
  <result pre="35]. Evidence supports a relationship between VNS and central and" exact="obstructive sleep apnea" post="[ 36, 37, 38], and caution should be exercised"/>
  <result pre="Evidence supports a relationship between VNS and central and obstructive" exact="sleep apnea" post="[ 36, 37, 38], and caution should be exercised"/>
  <result pre="best-studied and most widely used of the neuromodulatory modalities for" exact="epilepsy" post="in pediatric populations. It is safe, effective and FDA-approved."/>
  <result pre="and FDA-approved. Data support its use across a variety of" exact="epilepsy" post="types. 3. Responsive Neurostimulation 3.1. Introduction A responsive neurostimulation"/>
  <result pre="was FDA-approved in 2013 for the treatment of focal drug-resistant" exact="epilepsy" post="in adults [ 40]. Bergey, et al. reported a"/>
  <result pre="rates are similar to those of other intracranial devices or" exact="epilepsy" post="surgery [ 50, 51]. The RNS system is not"/>
  <result pre="seizure focus in patients who were presumed to have multifocal" exact="epilepsy" post="[ 55, 56]. There is limited data to support"/>
  <result pre="RNS use in pediatrics is limited to off-label implantations at" exact="epilepsy" post="centers familiar with its use in adult patients, and"/>
  <result pre="Deep brain stimulation (DBS) was FDA-approved for use in intractable" exact="epilepsy" post="in patients 18 years of age or older in"/>
  <result pre="The CMT has been targeted for the treatment of generalized" exact="epilepsy" post="[ 8, 60, 61, 62, 63, 64, 65]. A"/>
  <result pre="9) randomized-controlled trials of stimulation of the hippocampus for mesial" exact="temporal lobe epilepsy," post="with all three showing a reduction in seizure frequency"/>
  <result pre="Valentin et al. [ 76] described two children with generalized" exact="epilepsy" post="who underwent stimulation of the bilateral CMT, and one"/>
  <result pre="stimulation of the bilateral CMT, and one with right frontotemporal" exact="epilepsy" post="who underwent stimulation of the ANT for a period"/>
  <result pre="FDA-approved for dystonia in children [ 82]. Stimulation parameters in" exact="epilepsy" post="and movement can be similar [ 83]. Safety data"/>
  <result pre="Safety data are favorable, and may reasonably be extrapolated to" exact="epilepsy" post="[ 84]. Among the 40 patients included in a"/>
  <result pre="summarize, DBS is safe, effective and FDA-approved to treat intractable" exact="epilepsy" post="in adults, but data is lacking in pediatrics. Patient"/>
  <result pre="seizure frequency. Velasco, et al. described 10 patients with intractable" exact="temporal lobe epilepsy" post="who subsequently went on to have temporal lobectomies, and"/>
  <result pre="Velasco, et al. described 10 patients with intractable temporal lobe" exact="epilepsy" post="who subsequently went on to have temporal lobectomies, and"/>
  <result pre="indications, and is FDA-approved for the treatment of major depression," exact="migraine" post="and pre-surgical mapping of motor and language function ["/>
  <result pre="in 21 patients with malformations of cortical development and refractory" exact="epilepsy" post="[ 98]. Patient ages were not individually reported (mean"/>
  <result pre="106]. This tDCS has been studied in pediatric patients for" exact="attention deficit hyperactivity disorder" post="(ADHD), depression, cerebral palsy and autism spectrum disorder (ASD,"/>
  <result pre="in pediatric patients for attention deficit hyperactivity disorder (ADHD), depression," exact="cerebral palsy" post="and autism spectrum disorder (ASD, among which is Asperger’s"/>
  <result pre="for attention deficit hyperactivity disorder (ADHD), depression, cerebral palsy and" exact="autism" post="spectrum disorder (ASD, among which is Asperger’s Syndrome) ["/>
  <result pre="level of evidence to support the use of tDCS in" exact="epilepsy" post="is limited. Initial studies have shown promising results in"/>
  <result pre="only stimulation modality that is FDA-approved for the treatment of" exact="epilepsy" post="in pediatric patients. It is therefore the first option"/>
  <result pre="Data supporting the use of RNS or CSCS for generalized" exact="epilepsy" post="is limited or non-existent. Each modality has been effective"/>
  <result pre="parameters. 10. Conclusions Neurostimulation for the treatment of pharmacoresistant pediatric" exact="epilepsy" post="is safe and effective. Multiple options exist and can"/>
  <result pre="Berg A.T. Levy S.R. Testa F.M. D’Souza R. Remission of" exact="epilepsy" post="after two drug failures in children: A prospective study"/>
  <result pre="Pharmacoresistance and the role of surgery in difficult to treat" exact="epilepsy" post="Nat. Rev. Neurol. 2012 8 669 677 10.1038/nrneurol.2012.181 22964510"/>
  <result pre="10.1097/WCO.0000000000000534 29493559 8. Schulze-Bonhage A. Brain stimulation as a neuromodulatory" exact="epilepsy" post="therapy Seizure 2017 44 169 175 10.1016/j.seizure.2016.10.026 27876408 9."/>
  <result pre="Two-year seizure reduction in adults with medically intractable partial onset" exact="epilepsy" post="treated with responsive neurostimulation: Final results of the RNS"/>
  <result pre="AspireSR ® (including cardiac-based seizure detection) at a large complex" exact="epilepsy" post="and surgery centre Seizure 2018 58 120 126 10.1016/j.seizure.2018.03.022"/>
  <result pre="C. Dijk D.-J. Eriksson S.H. Dijk P.D.-J. Circadian rhythm and" exact="epilepsy" post="Lancet Neurol. 2018 17 1098 1108 10.1016/S1474-4422(18)30335-1 30366868 12."/>
  <result pre="Chang E.F. Rao V.R. Multi-day rhythms modulate seizure risk in" exact="epilepsy" post="Nat. Commun. 2018 9 88 10.1038/s41467-017-02577-y 29311566 13. Klinkenberg"/>
  <result pre="et al. Vagus nerve stimulation for pediatric patients with intractable" exact="epilepsy" post="between 3 and 6 years of age: Study protocol"/>
  <result pre="29284319 32. Ben-Menachem E. Vagus-nerve stimulation for the treatment of" exact="epilepsy" post="Lancet Neurol. 2002 1 477 482 10.1016/S1474-4422(02)00220-X 12849332 33."/>
  <result pre="G. Canevini M.P. Laryngeal motility alteration: A missing link between" exact="sleep apnea" post="and vagus nerve stimulation for epilepsy Epilepsia 2016 57"/>
  <result pre="missing link between sleep apnea and vagus nerve stimulation for" exact="epilepsy" post="Epilepsia 2016 57 24 27 10.1111/epi.13252 26696504 37. Forde"/>
  <result pre="Responsive neurostimulation: Review of clinical trials and insights into focal" exact="epilepsy" post="Epilepsy Behav. 2018 88 11 20 10.1016/j.yebeh.2018.06.042 41. Bergey"/>
  <result pre="Jobst B.C. Critical review of the responsive neurostimulator system for" exact="epilepsy" post="Med Devices: Évid. Res. 2015 8 405 411 45."/>
  <result pre="F.T. Responsive neurostimulation suppresses synchronized cortical rhythms in patients with" exact="epilepsy" post="Neurosurg. Clin. N. Am. 2011 22 481 488 10.1016/j.nec.2011.07.007"/>
  <result pre="K.I. Rao V.R. Responsive neurostimulation for treatment of pediatric drug-resistant" exact="epilepsy" post="Epilepsy Behav. Case Rep. 2018 10 21 24 10.1016/j.ebcr.2018.02.002"/>
  <result pre="Responsive cortical stimulation for the treatment of medically intractable partial" exact="epilepsy" post="Neurology 2011 77 1295 1304 10.1212/WNL.0b013e3182302056 21917777 50. Skarpaas"/>
  <result pre="50. Skarpaas T.L. Jarosiewicz B. Morrell M.J. Brain-responsive neurostimulation for" exact="epilepsy" post="(RNS((R)) System) Epilepsy Res. 2019 153 68 70 10.1016/j.eplepsyres.2019.02.003"/>
  <result pre="M.J. Differential neuropsychological outcomes following targeted responsive neurostimulation for partial-onset" exact="epilepsy" post="Epilepsia 2015 56 1836 1844 10.1111/epi.13191 26385758 54. Meador"/>
  <result pre="Quality of life and mood in patients with medically intractable" exact="epilepsy" post="treated with targeted responsive neurostimulation Epilepsy Behav. 2015 45"/>
  <result pre="C.N. Goldman A. Jobst B. et al. Lateralization of mesial" exact="temporal lobe epilepsy" post="with chronic ambulatory electrocorticography Epilepsia 2015 56 959 967"/>
  <result pre="A. Jobst B. et al. Lateralization of mesial temporal lobe" exact="epilepsy" post="with chronic ambulatory electrocorticography Epilepsia 2015 56 959 967"/>
  <result pre="of the anterior nucleus of thalamus for treatment of refractory" exact="epilepsy" post="Epilepsia 2010 51 899 908 10.1111/j.1528-1167.2010.02536.x 20331461 58. Salanova"/>
  <result pre="Long-term efficacy and safety of thalamic stimulation for drug-resistant partial" exact="epilepsy" post="Neurology 2015 84 1017 1025 10.1212/WNL.0000000000001334 25663221 59. Li"/>
  <result pre="59. Li M.C.H. Cook M.J. Deep brain stimulation for drug-resistant" exact="epilepsy" post="Epilepsia 2018 59 273 290 10.1111/epi.13964 29218702 60. Yan"/>
  <result pre="review of deep brain stimulation for the treatment of drug-resistant" exact="epilepsy" post="in childhood J. Neurosurg. Pediatr. 2018 23 274 284"/>
  <result pre="Mittal S. Deep brain stimulation for seizure control in drug-resistant" exact="epilepsy" post="Neurosurg. Focus 2018 45 E4 10.3171/2018.4.FOCUS1872 62. Laxpati N.G."/>
  <result pre="A. Koziara H. Nauman P. Deep brain stimulation for refractory" exact="epilepsy" post="Arch. Med. Sci. 2012 8 805 816 10.5114/aoms.2012.31135 23185188"/>
  <result pre="A. Kubu C.S. Wiebe S. Hippocampal electrical stimulation in mesial" exact="temporal lobe epilepsy" post="Neurology 2006 66 1490 1494 10.1212/01.wnl.0000209300.49308.8f 16554495 67. Velasco"/>
  <result pre="C.S. Wiebe S. Hippocampal electrical stimulation in mesial temporal lobe" exact="epilepsy" post="Neurology 2006 66 1490 1494 10.1212/01.wnl.0000209300.49308.8f 16554495 67. Velasco"/>
  <result pre="T. Jiménez-Jiménez D. et al. Intracranial stimulation for children with" exact="epilepsy" post="Eur. J. Paediatr. Neurol. 2017 21 223 231 10.1016/j.ejpn.2016.10.011"/>
  <result pre="Marson A.G. Boon P. Deep brain and cortical stimulation for" exact="epilepsy" post="Cochrane Database Syst. Rev. 2017 2017 CD008497 10.1002/14651858.CD008497.pub3 78."/>
  <result pre="and mood outcomes after anterior thalamic stimulation for refractory partial" exact="epilepsy" post="Seizure 2017 45 133 141 10.1016/j.seizure.2016.12.014 28061418 79. Oh"/>
  <result pre="long-term electrical stimulation of bilateral anterior thalamic nucleus in refractory" exact="epilepsy" post="patients Seizure 2012 21 183 187 10.1016/j.seizure.2011.12.003 22209542 80."/>
  <result pre="cortical stimulation: A therapeutic and potentially restorative therapy for focal" exact="epilepsy" post="Expert Rev. Neurother. 2017 17 661 666 10.1080/14737175.2017.1331129 28532252"/>
  <result pre="Schuh L. Smith B. Long-term electrical stimulation–induced inhibition of partial" exact="epilepsy" post="J. Neurosurg. 2006 105 894 897 10.3171/jns.2006.105.6.894 17405261 91."/>
  <result pre="Chronic subthreshold cortical stimulation and stimulation-related EEG biomarkers for focal" exact="epilepsy" post="Brain Comm. 2019 1 fcz010 10.1093/braincomms/fcz010 92. Child N.D."/>
  <result pre="Chronic subthreshold subdural cortical stimulation for the treatment of focal" exact="epilepsy" post="originating from eloquent cortex Epilepsia 2014 55 18 21"/>
  <result pre="side effects from chronic electrical stimulation for treatment of focal" exact="epilepsy" post="Brain Stimul. 2019 12 1077 1079 10.1016/j.brs.2019.03.077 30981622 96."/>
  <result pre="J. Nolan S.J. Transcranial magnetic stimulation for the treatment of" exact="epilepsy" post="Cochrane Database Syst. Rev. 2016 8 10.1002/14651858.CD011025.pub2 98. Fregni"/>
  <result pre="trial of repetitive transcranial magnetic stimulation in patients with refractory" exact="epilepsy" post="Ann. Neurol. 2006 60 447 455 10.1002/ana.20950 17068786 99."/>
  <result pre="Gschwind M. Seeck M. Transcranial direct-current stimulation as treatment in" exact="epilepsy" post="Expert Rev. Neurother. 2016 16 1427 1441 10.1080/14737175.2016.1209410 27384886"/>
  <result pre="simultaneous EEG recording: Preliminary assessment in healthy subjects and human" exact="epilepsy" post="Epilepsy Behav. 2012 25 417 425 10.1016/j.yebeh.2012.06.027 23123281 111."/>
  <result pre="al. Randomized controlled trial of trigeminal nerve stimulation for drug-resistant" exact="epilepsy" post="Neurology 2013 80 786 791 10.1212/WNL.0b013e318285c11a 23365066 120. Soss"/>
  <result pre="prospective long-term study of external trigeminal nerve stimulation for drug-resistant" exact="epilepsy" post="Epilepsy Behav. 2015 42 44 47 10.1016/j.yebeh.2014.10.029 25499162 121."/>
  <result pre="between the responses to ANT-DBS and prior VNS in refractory" exact="epilepsy" post="Brain Behav. 2018 8 e00983 10.1002/brb3.983 29740975 Figure 1"/>
 </snippets>
</snippetsTree>
